|
1
|
Olson AL and Pessin JE: Structure,
function, and regulation of the mammalian facilitative glucose
transporter gene family. Annu Rev Nutr. 16:235–256. 1996.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wang J, Ye C, Chen C, Xiong H, Xie B, Zhou
J, Chen Y, Zheng S and Wang L: Glucose transporter GLUT1 expression
and clinical outcome in solid tumors: A systematic review and
meta-analysis. Oncotarget. 8:16875–16886. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Kitamura K, Hatano E, Higashi T, Narita M,
Seo S, Nakamoto Y, Yamanaka K, Nagata H, Taura K, Yasuchika K, et
al: Proliferative activity in hepatocellular carcinoma is closely
correlated with glucose metabolism but not angiogenesis. J Hepatol.
55:846–857. 2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Macheda ML, Rogers S and Best JD:
Molecular and cellular regulation of glucose transporter (GLUT)
proteins in cancer. J Cell Physiol. 202:654–662. 2005.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Semaan A, Munkarah AR, Arabi H,
Bandyopadhyay S, Seward S, Kumar S, Qazi A, Hussein Y, Morris RT
and Ali-Fehmi R: Expression of GLUT-1 in epithelial ovarian
carcinoma: Correlation with tumor cell proliferation, angiogenesis,
survival and ability to predict optimal cytoreduction. Gynecol
Oncol. 121:181–186. 2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Paudyal B, Oriuchi N, Paudyal P, Higuchi
T, Nakajima T and Endo K: Expression of glucose transporters and
hexokinase II in cholangiocellular carcinoma compared using
[18F]-2-fluro-2-deoxy-D-glucose positron emission tomography.
Cancer Sci. 99:260–266. 2008.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kurokawa T, Yoshida Y, Kawahara K,
Tsuchida T, Okazawa H, Fujibayashi Y, Yonekura Y and Kotsuji F:
Expression of GLUT-1 glucose transfer, cellular proliferation
activity and grade of tumor correlate with
[F-18]-fluorodeoxyglucose uptake by positron emission tomography in
epithelial tumors of the ovary. Int J Cancer. 109:926–932.
2004.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kim TH, Kwak Y, Song C, Lee HS, Kim DW, Oh
HK, Kim JW, Lee KW, Kang SB and Kim JS: GLUT-1 may predict
metastases and death in patients with locally advanced rectal
cancer. Front Oncol. 13(1094480)2023.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Baer SC, Casaubon L and Younes M:
Expression of the human erythrocyte glucose transporter Glut1 in
cutaneous neoplasia. J Am Acad Dermatol. 37:575–577.
1997.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Koch A, Lang SA, Wild PJ, Gantner S, Mahli
A, Spanier G, Berneburg M, Müller M, Bosserhoff AK and Hellerbrand
C: Glucose transporter isoform 1 expression enhances metastasis of
malignant melanoma cells. Oncotarget. 6:32748–32760.
2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wachsberger PR, Gressen EL, Bhala A,
Bobyock SB, Storck C, Coss RA, Berd D and Leeper DB: Variability in
glucose transporter-1 levels and hexokinase activity in human
melanoma. Melanoma Res. 12:35–43. 2002.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Fujisawa Y, Yoshino K, Kiyohara Y, Kadono
T, Murata Y, Uhara H, Hatta N, Uchi H, Matsushita S, Takenouchi T,
et al: The role of sentinel lymph node biopsy in the management of
invasive extramammary Paget's disease: Multi-center, retrospective
study of 151 patients. J Dermatol Sci. 79:38–42. 2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Laybutt DR, Thompson AL, Cooney GJ and
Kraegen EW: Selective chronic regulation of GLUT1 and GLUT4 content
by insulin, glucose, and lipid in rat cardiac muscle in vivo. Am J
Physiol. 273:1309–1316. 1997.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Liu Y, Cao Y, Zhang W, Bergmeier S, Qian
Y, Akbar H, Colvin R, Ding J, Tong L, Wu S, et al: A small-molecule
inhibitor of glucose transporter 1 downregulates glycolysis,
induces cell-cycle arrest, and inhibits cancer cell growth in vitro
and in vivo. Mol Cancer Ther. 11:1672–1682. 2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Xu YY, Wu TT, Zhou SH, Bao YY, Wang QY,
Fan J and Huang YP: Apigenin suppresses GLUT-1 and p-AKT expression
to enhance the chemosensitivity to cisplatin of laryngeal carcinoma
Hep-2 cells: An in vitro study. Int J Clin Exp Pathol. 7:3938–3947.
2014.PubMed/NCBI
|
|
16
|
Chen Q, Meng YQ, Xu XF and Gu J: Blockade
of GLUT1 by WZB117 resensitizes breast cancer cells to adriamycin.
Anticancer Drugs. 28:880–887. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kowalczyk A, Bodalska A, Miranowicz M and
Karłowicz-Bodalska K: Insights into novel anticancer applications
for apigenin. Adv Clin Exp Med. 26:1143–1146. 2017.PubMed/NCBI View Article : Google Scholar
|
